Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
Clinical trial NCT05953337 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05953337
- Sponsor
- ABK Biomedical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2027-02-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.